Epigenomics AG Total Current Liabilities

The latest total current liabilities for EPGNY is $5K as of June 2026. That compares with $36K in the prior-year period — down 86.1% year over year. Investors often review this figure alongside Epigenomics AG's historical trend and sector peers before judging valuation or financial health.

Over the past year, EPGNY's total current liabilities moved from $36K to $5K — a 86.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Epigenomics AG's operating scale or balance-sheet position.

A total current liabilities figure of $5K for EPGNY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EPGNY's total current liabilities ($5K), review year-over-year change from $36K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.